Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011
(2012) In Journal of Translational Medicine 10.- Abstract
- Europrise is a Network of Excellence supported by the European Commission within the 6th Framework programme from 2007 to 2012. The Network has involved over 50 institutions from 13 European countries together with 3 industrial partners and 6 African countries. The Network encompasses an integrated program of research, training, dissemination and advocacy within the field of HIV vaccines and microbicides. A central and timely theme of the Network is the development of the unique concept of co-usage of vaccines and microbicides. Training of PhD students has been a major task, and some of these post-graduate students have here summarized novel ideas emanating from presentations at the last annual Europrise meeting in Prague. The latest data... (More)
- Europrise is a Network of Excellence supported by the European Commission within the 6th Framework programme from 2007 to 2012. The Network has involved over 50 institutions from 13 European countries together with 3 industrial partners and 6 African countries. The Network encompasses an integrated program of research, training, dissemination and advocacy within the field of HIV vaccines and microbicides. A central and timely theme of the Network is the development of the unique concept of co-usage of vaccines and microbicides. Training of PhD students has been a major task, and some of these post-graduate students have here summarized novel ideas emanating from presentations at the last annual Europrise meeting in Prague. The latest data and ideas concerning HIV vaccine and microbicide studies are included in this review; these studies are so recent that the majority have yet to be published. Data were presented and discussed concerning novel immunisation strategies; microbicides and PrEP (alone and in combination with vaccines); mucosal transmission of HIV/SIV; mucosal vaccination; novel adjuvants; neutralizing antibodies; innate immune responses; HIV/SIV pathogenesis and disease progression; new methods and reagents. These-necessarily overlapping topics-are comprehensively summarised by the Europrise students in the context of other recent exciting data. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/3181265
- author
- organization
- publishing date
- 2012
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- HIV, Vaccine, Microbicide, PrEP
- in
- Journal of Translational Medicine
- volume
- 10
- publisher
- BioMed Central (BMC)
- external identifiers
-
- wos:000310027300001
- scopus:84863565487
- pmid:22784600
- ISSN
- 1479-5876
- DOI
- 10.1186/1479-5876-10-144
- language
- English
- LU publication?
- yes
- id
- a41400ea-56bf-477f-b0d2-b2e2d854b0b7 (old id 3181265)
- date added to LUP
- 2016-04-01 13:31:45
- date last changed
- 2025-04-04 14:28:07
@article{a41400ea-56bf-477f-b0d2-b2e2d854b0b7, abstract = {{Europrise is a Network of Excellence supported by the European Commission within the 6th Framework programme from 2007 to 2012. The Network has involved over 50 institutions from 13 European countries together with 3 industrial partners and 6 African countries. The Network encompasses an integrated program of research, training, dissemination and advocacy within the field of HIV vaccines and microbicides. A central and timely theme of the Network is the development of the unique concept of co-usage of vaccines and microbicides. Training of PhD students has been a major task, and some of these post-graduate students have here summarized novel ideas emanating from presentations at the last annual Europrise meeting in Prague. The latest data and ideas concerning HIV vaccine and microbicide studies are included in this review; these studies are so recent that the majority have yet to be published. Data were presented and discussed concerning novel immunisation strategies; microbicides and PrEP (alone and in combination with vaccines); mucosal transmission of HIV/SIV; mucosal vaccination; novel adjuvants; neutralizing antibodies; innate immune responses; HIV/SIV pathogenesis and disease progression; new methods and reagents. These-necessarily overlapping topics-are comprehensively summarised by the Europrise students in the context of other recent exciting data.}}, author = {{Ruffin, Nicolas and Borggren, Marie and Euler, Zelda and Fiorino, Fabio and Grupping, Katrijn and Hallengard, David and Javed, Aneele and Mendonca, Kevin and Pollard, Charlotte and Reinhart, David and Saba, Elisa and Sheik-Khalil, Enas and Skold, Annette and Ziglio, Serena and Scarlatti, Gabriella and Gotch, Frances and Wahren, Britta and Shattock, Robin J.}}, issn = {{1479-5876}}, keywords = {{HIV; Vaccine; Microbicide; PrEP}}, language = {{eng}}, publisher = {{BioMed Central (BMC)}}, series = {{Journal of Translational Medicine}}, title = {{Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011}}, url = {{https://lup.lub.lu.se/search/files/3431665/3737881.pdf}}, doi = {{10.1186/1479-5876-10-144}}, volume = {{10}}, year = {{2012}}, }